LENVIMA is a prescription medicine that is used to treat certain kinds of cancer.

  • LENVIMA is used by itself to treat differentiated thyroid cancer (DTC), a type of thyroid cancer that can no longer be treated with radioactive iodine and is progressing.
  • LENVIMA is used to treat adults with a type of kidney cancer called advanced renal cell carcinoma (RCC):
    • along with the medicine pembrolizumab as your first treatment when your kidney cancer has spread or cannot be removed by surgery.
    • along with the medicine everolimus after one course of treatment with another anti-cancer medicine.
  • LENVIMA is used by itself as the first treatment for a type of liver cancer called hepatocellular carcinoma (HCC) when it cannot be removed by surgery.
  • LENVIMA is used along with another medicine called pembrolizumab to treat advanced endometrial carcinoma (EC), a type of uterine cancer:
    • when a laboratory test shows that your tumor is mismatch repair proficient (pMMR) or not microsatellite instability high (MSI-H), and
    • you have received anti-cancer treatment, and it is no longer working, and
    • your cancer cannot be cured by surgery or radiation

It is not known if LENVIMA is safe and effective in children.

View full indication
Important Safety Information & Full Prescribing Information
LENVIMA

Unsubscribe

If you wish to unsubscribe or opt out of receiving future LENVIMA email communications, please enter your email address and click the submit button below.

You have successfully opted out of receiving LENVIMA email communications.

We are experiencing technical difficulties. Please try again later. We apologize for the inconvenience and thank you for your patience.